The relevance of this novel LPS/TLR-4/LITAF signalling in regulating potential development of hepatic inflammation and fibrosis that characterizes NASH is emphasised by the fact that children affected by this disease frequently display also a pattern of low-grade systemic inflammation. This evidence concerns the gene TLR4 and metabolic dysfunction-associated steatohepatitis.